News

• Sanofi and Regeneron announce intent to restructure Antibody collaboration for Kevzara® (sarilumab) and Praluent® (alirocumab)
  14:30 - GlobeNewswire
•  
• Ziopharm Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
  12/09/2019 / 23:00 - GlobeNewswire
•  
• Ziopharm Oncology Presents Pre-Clinical Data Validating “Rapid Personalized Manufacture” (RPM) with TCR at the 2019 American Society for Hematology Annual Meeting
  12/08/2019 / 15:00 - GlobeNewswire
•  
• Ziopharm Oncology Presents Encouraging Clinical Data for Controlled IL-12 for the Treatment of Recurrent Glioblastoma at the 2019 Society for Neuro-Oncology Annual Meeting
  11/23/2019 / 15:00 - GlobeNewswire
•  
• Kiniksa Announces Breakthrough Therapy Designation for Rilonacept for the Treatment of Recurrent Pericarditis
  11/20/2019 / 14:00 - GlobeNewswire
•  
• Ziopharm Oncology Updates Presentation and Webcast Time at the Jefferies 2019 London Healthcare Conference
  11/18/2019 / 13:00 - GlobeNewswire
•  
• Kiniksa Presents Rilonacept Final Phase 2 Clinical Data at the American Heart Association Scientific Sessions 2019
  11/16/2019 / 18:00 - GlobeNewswire
•  
• Ziopharm Oncology Presentation at the Jefferies 2019 London Healthcare Conference to be Webcast
  11/11/2019 / 15:10 - GlobeNewswire
•  
• Wall Street closes at new record highs
  11/08/2019 / 22:00 - TeleTrader
•  
• Ziopharm Oncology Reports Third Quarter 2019 Financial Results
  11/07/2019 / 22:05 - GlobeNewswire
•  
• Coherus BioSciences Reports Corporate Highlights and Third Quarter 2019 Financial Results
  11/06/2019 / 22:01 - GlobeNewswire
•  
• Biogen to Expand Biosimilars Portfolio and Gain Access to Additional Markets Through New Transaction with Samsung Bioepis
  11/06/2019 / 13:30 - GlobeNewswire
•  
• Wall Street starts higher on buoyed trade deal hopes
  11/05/2019 / 15:30 - TeleTrader
•  
• Intellia Therapeutics Announces Third Quarter 2019 Financial Results
  10/31/2019 / 12:30 - GlobeNewswire
•  
• Ziopharm Oncology to Host Conference Call to Discuss Third Quarter 2019 Results on November 7, 2019
  10/30/2019 / 13:30 - GlobeNewswire